Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy and radiation therapy with or without epoetin alfa in stage IIIA/IIIB non-small cell lung cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED